Detalles de la búsqueda
1.
Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy.
Br J Clin Pharmacol;
88(3): 1189-1201, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34449090
2.
Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization.
Br J Clin Pharmacol;
87(3): 1359-1368, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32808306
3.
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier.
Br J Clin Pharmacol;
85(1): 181-193, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30302786
4.
Results and evaluation of a first-in-human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods.
Br J Clin Pharmacol;
84(3): 445-455, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096426
5.
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline.
Eur J Nucl Med Mol Imaging;
44(3): 382-391, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27633250
6.
Effect of varying degrees of renal impairment on the pharmacokinetics and tolerability of taspoglutide.
Diabetes Obes Metab;
19(4): 537-544, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27981717
7.
No evidence of QT prolongation with supratherapeutic doses of aleglitazar.
J Cardiovasc Pharmacol;
59(3): 288-97, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22113345
8.
Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants.
Clin Pharmacol Ther;
108(1): 126-135, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31957010
9.
Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza.
Open Forum Infect Dis;
6(10): ofz430, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31660381
10.
Assessment of Drug-Drug Interactions between Taspoglutide, a Glucagon-Like Peptide-1 Agonist, and Drugs Commonly Used in Type 2 Diabetes Mellitus: Results of Five Phase I Trials.
Clin Pharmacokinet;
58(9): 1205-1214, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30968335
11.
Early pediatric formulation development with new chemical entities: Opportunities of e-tongue besides human taste assessment.
Int J Pharm;
530(1-2): 201-212, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28750893
12.
Metabolism, excretion, and pharmacokinetics of [14c]-radiolabeled aleglitazar: a phase I, nonrandomized, open-label, single-center, single-dose study in healthy male volunteers.
Clin Ther;
34(2): 420-9, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22244809
13.
On stiffness of scaffolds for bone tissue engineering-a numerical study.
J Biomech;
43(9): 1738-44, 2010 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-20227080
14.
An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography-tandem mass spectrometry.
J Chromatogr B Analyt Technol Biomed Life Sci;
878(28): 2726-32, 2010 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20846915
Resultados
1 -
14
de 14
1
Próxima >
>>